1. Home
  2. SHO vs SUPN Comparison

SHO vs SUPN Comparison

Compare SHO & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHO
  • SUPN
  • Stock Information
  • Founded
  • SHO 1995
  • SUPN 2005
  • Country
  • SHO United States
  • SUPN United States
  • Employees
  • SHO N/A
  • SUPN N/A
  • Industry
  • SHO Hotels/Resorts
  • SUPN Biotechnology: Pharmaceutical Preparations
  • Sector
  • SHO Consumer Discretionary
  • SUPN Health Care
  • Exchange
  • SHO Nasdaq
  • SUPN Nasdaq
  • Market Cap
  • SHO 1.7B
  • SUPN 2.0B
  • IPO Year
  • SHO 1995
  • SUPN 2012
  • Fundamental
  • Price
  • SHO $9.57
  • SUPN $44.90
  • Analyst Decision
  • SHO Hold
  • SUPN Buy
  • Analyst Count
  • SHO 7
  • SUPN 2
  • Target Price
  • SHO $9.36
  • SUPN $41.00
  • AVG Volume (30 Days)
  • SHO 2.4M
  • SUPN 1.1M
  • Earning Date
  • SHO 08-06-2025
  • SUPN 08-05-2025
  • Dividend Yield
  • SHO 3.77%
  • SUPN N/A
  • EPS Growth
  • SHO N/A
  • SUPN 1411.53
  • EPS
  • SHO 0.02
  • SUPN 1.14
  • Revenue
  • SHO $934,999,000.00
  • SUPN $665,125,000.00
  • Revenue This Year
  • SHO $6.65
  • SUPN $4.84
  • Revenue Next Year
  • SHO $3.72
  • SUPN $17.69
  • P/E Ratio
  • SHO $503.26
  • SUPN $38.74
  • Revenue Growth
  • SHO 0.37
  • SUPN 5.55
  • 52 Week Low
  • SHO $7.45
  • SUPN $29.16
  • 52 Week High
  • SHO $12.41
  • SUPN $45.60
  • Technical
  • Relative Strength Index (RSI)
  • SHO 63.75
  • SUPN 73.64
  • Support Level
  • SHO $9.23
  • SUPN $43.77
  • Resistance Level
  • SHO $9.59
  • SUPN $45.60
  • Average True Range (ATR)
  • SHO 0.22
  • SUPN 1.23
  • MACD
  • SHO 0.06
  • SUPN 0.05
  • Stochastic Oscillator
  • SHO 97.96
  • SUPN 86.65

About SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in Califiornia which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its hotel ownership segment.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: